GC Cell Corporation
Clinical trials sponsored by GC Cell Corporation, explained in plain language.
GC Cell Corporation
144510
KOSDAQ
A South Korean biotech company specializing in cell and gene therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Engineered immune cells take aim at hard-to-treat blood cancers Results expected Aug 2027 (estimated)